Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial-Reference-Cited by-同舟云学术

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

Published:2020-07 Issue:10244 Volume:396 Page:110-120
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rosmarin David,Pandya Amit G,Lebwohl Mark,Grimes Pearl,Hamzavi Iltefat,Gottlieb Alice B,Butler Kathleen,Kuo Fiona,Sun Kang,Ji Tao,Howell Michael D,Harris John E

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Clinical practice. Vitiligo;Taïeb;N Engl J Med,2009

2. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients;van den Boorn;J Invest Dermatol,2009

3. A review of the worldwide prevalence of vitiligo in children/adolescents and adults;Kruger;Int J Dermatol,2012

4. Quality of life in people with vitiligo: a systematic review and meta-analysis;Morrison;Br J Dermatol,2017

5. Association of vitiligo with hospitalization for mental health disorders in US adults;Patel;J Eur Acad Dermatol Venereol,2019

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis;Journal of Dermatological Treatment;2024-09

2. Januskinaseinhibitoren für dermatologische Erkrankungen;Die Dermatologie;2024-08-30

3. A meta-analysis of therapeutic trials of topical ruxolitinib cream for the treatment of vitiligo: therapeutic efficacy, safety, and implications for therapeutic practice;Archives of Dermatological Research;2024-08-12

4. Clinical and Psychological Implications of Genital Vitiligo in a Thai Population;Journal of Cutaneous Medicine and Surgery;2024-08-11

5. Up-and-Coming Drugs for the Treatment of Vitiligo;ANN DERMATOL;2024